|
[1]Yedidia Y, Horonchik L, Tzaban S, et al:Proteasomes and ubiquit-in are involved in the turnover of the wild-type prion protein[J].EMBO J, 2001, 20 (19) ∶5383-5391.
|
|
[2]Roccaro AM, Hideshima T, Richardson PG, et al.Bortezomib as anantitumor agent[J].Curr PharmBiotechnol, 2006, 7 (6) ∶441-448.
|
|
[3]吴慧娟, 张志刚.泛素蛋白酶体途径及意义[J].国际病理科学与临床杂志, 2006, 26 (1) ∶7-10.
|
|
[4]倪晓光, 赵平.泛素—蛋白酶体途径的组成和功能[J].生理科学进展, 2006, 37 (3) ∶255-258.
|
|
[5]李朝飞, 庞义.泛素-蛋白水解酶复合体通路与病毒侵染[J].生物工程学报, 2004, 20 (2) ∶151-156.
|
|
[6]Mayer RJ.From neurodegeneration to neurohomeostasis:the role ofubiquitin[J].Drug News Perspect, 2003, 16 (2) ∶103-108.
|
|
[7]Scrofano MM, Shang F, Nowell TR Jr, et al.Aging, calorie restric-tion and ubiquitin-dependent proteolysis in the livers of Emorymice[J].Mech Ageing Dev, 1998, 101 (3) ∶277-296.
|
|
[8]黄敏, 丁健.抗肿瘤药物新靶点[J].中国处方药, 2006, 12 (57) ∶14-16.
|
|
[9]Joshi-Barve S, Barve SS, Butt W, et al.Inhibition of proteasomefunction leads to NF-kappaB-independent IL-8 expression in hu-man hepatocytes[J].Hepatology, 2003, 38 (5) ∶1178-1187.
|
|
[10]Bardag-Gorce F, van Leeuwen FW, Nguyen V, et al.The role ofthe ubiquitin-proteasome pathway in the formation of mallorybodies[J].Exp Mol Pathol, 2002, 73 (2) ∶75-83.
|
|
[11]唐大年, 韦军民, 朱明炜, 等.阻断泛素—蛋白酶体通路与人肝癌细胞药物敏感性关系的实验研究[J].中华肝胆外科杂志, 2006, 12 (9) ∶634-636.
|
|
[12]Della Fazia MA, Castelli M, Bartoli D, et al.HOPS:a novel cAMP-dependent shuttling protein involved in protein synthesisregulation[J].J Cell Sci, 2005, 118 (14) ∶3185-3194.
|
|
[13]Shirahashi H, Sakaida I, Terai S, et al.Ubiquitin is a possible newpredictive marker for the recurrence of human hepatocellular carcino-ma[J].Liver, 2002, 22 (5) ∶413-418.
|
|
[14]Zhang Z, Torii N, Furusaka A, et al.Structural and functionalcharacterization of interaction between hepatitis B virus X protein andthe proteasome complex[J].J Biol Chem, 2000, 275 (20) ∶15157-15165.
|
|
[15]Rost M, Mann S, Lambert C, et al.Gamma-adaptin, a novelubiquitin-interacting adaptor, and Nedd4 ubiquitin ligase controlhepatitis B virus maturation[J].J Biol Chem, 2006, 281 (39) ∶29297-29308.
|
|
[16]Suzuki R, Tamura K, Li J, et al.Ubiquitin-mediated degradationof hepatitis C virus core protein is regulated by processing at its car-boxyl terminus[J].Virology, 2001, 280 (2) ∶301-309.
|
|
[17]Gao L, Tu H, Shi ST, et al.Interaction with a ubiquitin-like pro-tein enhances the ubiquitination and degradation of hepatitis C virusRNA-dependent RNA polymerase[J].J Virol, 2003, 77 (7) ∶4149-4159.
|
|
[18]Schlax PE, Zhang J, Lewis E, et al.Degradation of the encephalo-myocarditis virus and hepatitis Avirus3C proteases by the ubiquitin/26S proteasome system in vivo[J].Virology, 2007, 360 (2) ∶350-363.
|
|
[19]Losick VP, Schlax PE, Emmons RA, et al.Signals in hepatitis Avirus P3 region proteins recognized by the ubiquitin-mediated prote-olytic system[J].Virology, 2003, 309 (2) ∶306-319.
|
|
[20]Fortun J, Li J, Go J, et al.Impaired proteasome activity and accu-mulation of ubiquitinated substrates in a hereditary neuropathymodel[J].J Neurochem, 2005, 92 (6) ∶1531-1541.
|
PDF下载 ( 173 KB)
本文二维码
下载:
